TURBT后病理组织标本中肌层组织存在与否作为预测手术质量指标的可行性研究

王文龙; 张羽; 胡海龙; 王意涵; 李胜; 邢晨; 吴长利

doi:10.13201/j.issn.1001-1420.2015.05.011

TURBT后病理组织标本中肌层组织存在与否作为预测手术质量指标的可行性研究

- 天津医科大学第二医院泌尿外科, 天津市泌尿外科研究所, 天津市泌尿外科基础医学重点实验室(天津, 300211)
基金项目:
国家自然科学基金资助项目（编号30700834）；天津市自然科学基金资助项目（编号12ZCDZSY16600）1

详细信息

通讯作者: 吴长利,E-mail:wucl2003@163.com

中图分类号: R737.14

收稿日期: 2014-11-03

Feasibility study on prediction of operation quality index by existence or non-existence muscle tissues in pathological specimens from TURBT

- Department of Urology, Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin Key Laboratory of Basic Medicine of Urology, Tianjin, 300211, China

More Information

Corresponding author: WU Changli, E-mail: wucl2003@163.com

Received Date: 03 November 2014

摘要

摘要: 目的：探讨经尿道膀胱肿瘤电切术（TURBT）后病理组织标本中有无肌层组织是否可以作为评价手术质量的指标。方法：回顾性分析2013年1月~2013年12月收治的339例行TURBT治疗的膀胱癌患者临床资料，并观察其病理组织切片，评价肿瘤的大小、数目、形态、位置、分期和分级与病理切片中是否存在肌层组织的关系，并评价是否存在肌层与肿瘤复发的关系。结果：339例患者中，病理组织切片中存在肌层组织的患者272例（80.24%）。单因素分析表明肿瘤分期、分级及大小与病理组织切片中有无肌层组织相关。T_a/T₁期肿瘤病理组织切片中存在肌层和不存在肌层患者的复发率分别为30.00%和44.78%，P=0.003，差异具有统计学意义。结论：TURBT后病理组织切片中是否存在肌层与肿瘤的复发相关，从而可以作为评价TURBT手术质量的指标。该指标可指导术者更彻底切除肿瘤，降低肿瘤复发率，在非肌层浸润性膀胱癌诊治中具有重要临床价值。
- 膀胱癌 /
- 经尿道膀胱肿瘤电切术 /
- 肿瘤复发 /
- 肌层组织
Abstract: Objective: To evaluate whether the presence of detrusor muscle in bladder tumor specimens after transurethral resection can be a significant marker of surgery quality.Method: All of 339 cases with bladder cancer were treated with transurethral resection of bladder tumor (TURBT) from January 2013 to December 2013 and their tumor specimens were reviewed. The end points were non-existence or existence of detrusor muscles in the surgical specimen and its association with tumor's shape, number, size, position, stage, grade and disease recurrence.Result: Detrusor muscle in the surgical specimen was found in 272 of the 339 study patients (80.24%). Univariate analyses revealed that the size, stage and grade of tumor were associated with the presence of detrusor muscle in the resected specimens. The recurrence of T_a or T₁ tumor between attendance of detrusor muscle group and absence of detrusor muscle group was statistically significant, with a recurrence rate of 30.00% and 44.78%, respectively (P=0.003).Conclusion: The presence or absence of detrusor muscle in apparently complete TURBT specimen shows significant association with recurrence and may be an important marker of resection quality. Moreover, it can be clinical helpful to effectively resect the lesions for surgeon and lead to a lower recurrence.
- urinary bladder neoplasms /
- transurethral resection of bladder tumor /
- recurrence /
- detrusor muscle

HTML全文

参考文献(13)

[1]	Freeman J A, Esrig D, Stein J P, et al.Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction[J].Cancer, 1995, 76(5):833-839.
[2]	Maruniak N A, Takezawa K, Murphy W M.Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling[J].J Urol, 2002, 167(6):2404-2407.
[3]	Mariappan P, Zachou A, Grigor K M.Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience[J].Eur Urol, 2010, 57(5):843-849.
[4]	Herr H W, Donat S M.Quality control in transurethral resection of bladder tumours[J].BJU Int, 2008, 102(9Pt B):1242-1246.
[5]	Holzbeierlein J M, Smith J J.Surgical management of noninvasive bladder cancer(stages Ta/T1/CIS)[J].Urol Clin North Am, 2000, 27(1):15-24.
[6]	Knowles M A.Bladder cancer subtypes defined by genomic alterations[J].Scand J Urol Nephrol Suppl, 2008, (218):116-30.
[7]	Brausi M, Collette L, Kurth K, et al.Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1transitional cell carcinoma of the bladder:a combined analysis of seven EORTC studies[J].Eur Urol, 2002, 41(5):523-531.
[8]	Pan D, Soloway M S.The importance of transurethral resection in managing patients with urothelial cancer in the bladder:proposal for a transurethral resection of bladder tumor checklist[J].Eur Urol, 2012, 61(6):1199-1203.
[9]	Dalbagni G, Herr H W, Reuter V E.Impact of a second transurethral resection on the staging of T1 bladder cancer[J].Urology, 2002, 60(5):822-824, 824-825.
[10]	Herr H W.The value of a second transurethral resection in evaluating patients with bladder tumors[J].J Urol, 1999, 162(1):74-76.
[11]	Dutta S C, Smith J J, Shappell S B, et al.Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy[J].J Urol, 2001, 166(2):490-493.
[12]	Divrik R T, Yildirim U, Zorlu F, et al.The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin:a prospective, randomized clinical trial[J].J Urol, 2006, 175(5):1641-1644.
[13]	Shoshany O, Mano R, Margel D, et al.Presence of detrusor muscle in bladder tumor specimens——predictors and effect on outcome as a measure of resection quality[J].Urol Oncol, 2014, 32(1):17-40.